Literature DB >> 32911997

Alcohol, Tobacco, and Comorbid Psychiatric Disorders and Associations With Sexual Identity and Stress-Related Correlates.

Rebecca J Evans-Polce1, Luisa Kcomt1, Philip T Veliz1, Carol J Boyd1, Sean Esteban McCabe1.   

Abstract

OBJECTIVE: The authors examined psychiatric comorbidities associated with alcohol use disorders and tobacco use disorders among heterosexual, bisexual, and gay and lesbian men and women in the United States and whether stress-related factors were predictive of comorbidities.
METHODS: The authors used data from the National Epidemiologic Survey on Alcohol and Related Conditions-III (2012-2013, N=36,309) to examine the co-occurrence of past-year alcohol or tobacco use disorder with past-year anxiety disorders, mood disorders, and posttraumatic stress disorder by sexual identity (heterosexual, bisexual, gay or lesbian) and sex. The authors also examined the association of stress-related factors and social support with the presence of comorbidities.
RESULTS: Comorbidities were more prevalent among women and sexual minorities, particularly bisexual women. More than half of bisexual (55%) and gay or lesbian (51%) individuals who met criteria for a past-year alcohol use disorder had a psychiatric comorbidity, while only one-third of heterosexual individuals who met criteria for a past-year alcohol use disorder did. Similar differences were found among those who met criteria for a past-year tobacco use disorder. Among sexual minorities, the frequency of sexual orientation discrimination (adjusted odds ratio range=1.08-1.10), number of stressful life events (adjusted odds ratio range=1.25-1.43), and number of adverse childhood experiences (adjusted odds ratio range=1.04-1.18) were significantly associated with greater odds of comorbidities. Greater social support was significantly inversely associated with tobacco use disorder comorbidities (adjusted odds ratio range=0.96-0.97).
CONCLUSIONS: This research suggests that integrated substance use and mental health prevention and treatment programs are needed, particularly for individuals who identify as sexual minorities. The increased stressors experienced by sexual minority individuals may be important drivers of these high levels of comorbidities.

Entities:  

Keywords:  Bisexual; Gay; Lesbian; Substance-Related and Addictive Disorders; Transgender (LGBT) Disparities

Mesh:

Year:  2020        PMID: 32911997      PMCID: PMC7606786          DOI: 10.1176/appi.ajp.2020.20010005

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  35 in total

Review 1.  Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes.

Authors:  Pablo Najt; Paolo Fusar-Poli; Paolo Brambilla
Journal:  Psychiatry Res       Date:  2010-08-21       Impact factor: 3.222

2.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  Clinical presentations, social functioning, and treatment receipt among individuals with comorbid life-time PTSD and alcohol use disorders versus drug use disorders: findings from NESARC-III.

Authors:  Tracy L Simpson; Peter Rise; Kendall C Browne; Keren Lehavot; Debra Kaysen
Journal:  Addiction       Date:  2019-03-10       Impact factor: 6.526

4.  The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample.

Authors:  Bridget F Grant; Rise B Goldstein; Sharon M Smith; Jeesun Jung; Haitao Zhang; Sanchen P Chou; Roger P Pickering; Wenjun J Ruan; Boji Huang; Tulshi D Saha; Christina Aivadyan; Eliana Greenstein; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2014-12-08       Impact factor: 4.492

5.  Associations between sexual orientation discrimination and substance use disorders: differences by age in US adults.

Authors:  Rebecca J Evans-Polce; Phillip T Veliz; Carol J Boyd; Tonda L Hughes; Sean Esteban McCabe
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-03-22       Impact factor: 4.328

6.  The impact of institutional discrimination on psychiatric disorders in lesbian, gay, and bisexual populations: a prospective study.

Authors:  Mark L Hatzenbuehler; Katie A McLaughlin; Katherine M Keyes; Deborah S Hasin
Journal:  Am J Public Health       Date:  2010-01-14       Impact factor: 9.308

7.  Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology.

Authors:  K R Merikangas; R L Mehta; B E Molnar; E E Walters; J D Swendsen; S Aguilar-Gaziola; R Bijl; G Borges; J J Caraveo-Anduaga; D J DeWit; B Kolody; W A Vega; H U Wittchen; R C Kessler
Journal:  Addict Behav       Date:  1998 Nov-Dec       Impact factor: 3.913

8.  Sexual orientation, substance use behaviors and substance dependence in the United States.

Authors:  Sean Esteban McCabe; Tonda L Hughes; Wendy B Bostwick; Brady T West; Carol J Boyd
Journal:  Addiction       Date:  2009-05-12       Impact factor: 6.526

9.  Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders.

Authors:  Kara R Douglas; Grace Chan; Joel Gelernter; Albert J Arias; Raymond F Anton; Roger D Weiss; Kathleen Brady; James Poling; Lindsay Farrer; Henry R Kranzler
Journal:  Addict Behav       Date:  2009-08-08       Impact factor: 3.913

10.  Disparities in substance use behaviors and disorders among adult sexual minorities by age, gender, and sexual identity.

Authors:  Megan S Schuler; Cara E Rice; Rebecca J Evans-Polce; Rebecca L Collins
Journal:  Drug Alcohol Depend       Date:  2018-06-19       Impact factor: 4.852

View more
  7 in total

1.  Discrimination and alcohol problems among heavy drinking HIV-positive men who have sex with men: The buffering effect of a brief Motivational Intervention to reduce alcohol use.

Authors:  Arryn A Guy; David G Zelaya; Anthony Surace; Nadine R Mastroleo; David W Pantalone; Peter M Monti; Kenneth H Mayer; Christopher W Kahler
Journal:  Drug Alcohol Depend       Date:  2022-03-02       Impact factor: 4.492

2.  A latent class analysis of tailored substance use treatment programs: Implications for treating syndemic conditions facing sexual and gender minority populations.

Authors:  Emily C Helminen; Cory J Cascalheira; Thomas J Shaw; Sarah Zollweg; Tonda L Hughes; Jillian R Scheer
Journal:  Drug Alcohol Depend       Date:  2022-06-30       Impact factor: 4.852

3.  Impact of the policy environment on substance use among sexual minority women.

Authors:  Laurie A Drabble; Cat Munroe; Amy A Mericle; Sarah Zollweg; Karen F Trocki; Katherine J Karriker-Jaffe
Journal:  Drug Alcohol Depend Rep       Date:  2022-04-29

4.  PTSD Symptoms and Hazardous Drinking Indicators among Trauma-Exposed Sexual Minority Women during Heightened Societal Stress.

Authors:  Emily C Helminen; Jillian R Scheer; Skyler D Jackson; Cal D Brisbin; Abigail W Batchelder; Cory J Cascalheira; Tami P Sullivan
Journal:  Behav Med       Date:  2021-12-06       Impact factor: 3.879

5.  Alcohol use, behavioral and mental health help-seeking, and treatment satisfaction among sexual minority women.

Authors:  Jillian R Scheer; Abigail W Batchelder; Lauren A Bochicchio; Jeremy D Kidd; Tonda L Hughes
Journal:  Alcohol Clin Exp Res       Date:  2022-03-22       Impact factor: 3.928

6.  Nicotine and Tobacco Product Use and Dependence Symptoms Among US Adolescents and Adults: Differences by Age, Sex, and Sexual Identity.

Authors:  Rebecca J Evans-Polce; Philip Veliz; Luisa Kcomt; Carol J Boyd; Sean Esteban McCabe
Journal:  Nicotine Tob Res       Date:  2021-11-05       Impact factor: 5.825

7.  Sexual identity differences in biomarkers of tobacco exposure among women in a national sample.

Authors:  Rebecca J Evans-Polce; Danielle M Smith; Philip Veliz; Carol J Boyd; Sean Esteban McCabe
Journal:  Cancer Epidemiol       Date:  2021-07-08       Impact factor: 2.890

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.